Market Trends Merck inks $2B licensing deal with Jiangsu Hengrui (MRK:NYSE)By admin8996erT0allMarch 25, 2025 Erik S. Lesser/Getty Images NewsMerck (NYSE:MRK) has reached a licensing agreement worth nearly $2B with the Chinese drugmaker Jiangsu Hengrui…
